Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Rights to the proprietary formulation of a medical product. It consists of proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye. Budesonide is provided for the treatment of asthma.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Primary Office
- Italy
Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.
Request full access to PitchBookTeva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.
Request full access to PitchBook